Leerink Partners analyst Roanna Ruiz has maintained their bullish stance on LXRX stock, giving a Buy rating yesterday.Invest with Confidence: ...

Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.

In advance of topline data from the Phase 2b PROGRESS trial anticipated later this quarter, the event will offer an in-depth overview on LX9211 for the treatment of diabetic peripheral neuropathic ...

Transcutaneous electrical nerve stimulation (TENS) may help provide pain relief for people with diabetic neuropathy. However, more research is necessary. Some research suggests that high and low ...

Our goal is to provide novel therapeutic modalities that would not only alleviate neuropathic pain in patients with diabetes but, even more importantly, also halt its progression without causing ...

the event will offer an in-depth overview on LX9211 for the treatment of diabetic peripheral neuropathic pain (DPNP), featuring remarks from Lexicon leaders including: Mike Exton, PhD, Chief ...

EC-5026 is under clinical development by Eicosis and currently in Phase I for Diabetic Neuropathic Pain. According to GlobalData, Phase I drugs for Diabetic Neuropathic Pain have a 94% phase ...

Have you experienced pain or tingling in your hands or feet? Those are signs of possible neuropathy, “a general term for ...

Diabetic Peripheral Neuropathy (DPN): A type of nerve damage that occurs in people with diabetes, leading to pain, numbness, and weakness, particularly in the extremities. Hyperglycemia ...